TILs infiltration, expression of immune-marker such as PD-L1, TMB and MMRd/MSI status are well-known markers suggesting response to treatment in epithelial cancer or in very immunogenic cancers like melanoma (10–14) (32–34). The gene discussed is CD274; the disease is melanoma.